一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Advanced Healthcare Materials >>article
Advanced Healthcare Materials

Advanced Healthcare Materials

IF: 10
Download PDF

Prim-O-Glucosylcimifugin Repairs Diabetic Tendon Injury by Rescuing Tendon Stem/Progenitor Cell Hypofunction Through AMPK Pathway Activation

Published:11 June 2025 DOI: 10.1002/adhm.202501239 PMID: 40500937
Yu Wang, Lisha Zhu, Hangbo Liu, Shanshan Jin, Xiaolan Wu, Tianhao Wu, Yan Liu

Abstract

Patients with diabetes face an increased risk of developing several tendon disorders, such as tendinopathy, tendon rupture, and impaired tendon healing. Tendon stem/progenitor cells (TSPCs) play a crucial role in maintaining tendon tissue homeostasis and facilitating tendon healing. However, under diabetic conditions, TSPC dysfunction contributes to the development and progression of tendinopathy or tendon injury. Despite this, effective treatments remain limited. This study aims to investigate the potential of prim-O-glucosylcimifugin (POG) in preventing high glucose (HG)-induced senescence and restoring the impaired regenerative phenotype of TSPCs. The results reveal that HG stimulation induces TSPC senescence, characterized by impaired self-renewal capacity, increased expression of senescence markers, and reduced tenogenic differentiation potential. Notably, treatment with POG counteracts HG-induced senescence, restoring the impaired tenogenic differentiation capacity through AMP-activated protein kinase (AMPK) pathway activation. To assess the in vivo effect of POG, mesoporous silica nanoparticles are employed for the local delivery of POG. This approach efficiently promotes tendon healing in diabetic mice with partial-cut-induced tendon injury. Moreover, the combination of POG and biomimetic scaffold transplantation functionally rescues endogenous tendon regeneration and repair capacities in diabetic mice. In conclusion, pharmacological intervention with POG can rescue HG-induced TSPC hypofunction and promote tendon healing under diabetic conditions.

Substances (4)

Materials
Procduct Name CAS Molecular Formula Supplier Price
CIMIFUGIN BETA-D-GLUCOPYRANOSIDE 80681-45-4 C22H28O11 300 suppliers $36.00-$1012.12
CIMIFUGIN BETA-D-GLUCOPYRANOSIDE 80681-45-4 C22H28O11 300 suppliers $36.00-$1012.12
CIMIFUGIN BETA-D-GLUCOPYRANOSIDE 80681-45-4 C22H28O11 300 suppliers $36.00-$1012.12
CIMIFUGIN BETA-D-GLUCOPYRANOSIDE 80681-45-4 C22H28O11 300 suppliers $36.00-$1012.12

Similar articles

IF:10

Coaxial Electrospun Nanofibrous Membranes as Dual‐Functional Biomimetic Tendon Sheath for Tendon Repair and Anti‐Peritendinous Adhesion

Advanced Healthcare Materials Qiao Yang, Jianfeng Li,etc Published: 26 November 2024
IF:5.3

BMP10 Knockdown Modulates Endothelial Cell Immunoreactivity by Inhibiting the HIF‐1α Pathway in the Sepsis‐Induced Myocardial Injury

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE Huan Guan, Jingyun Fang,etc Published: 29 November 2024
巍山| 天峨县| 新宁县| 武定县| 安徽省| 大方县| 化州市| 边坝县| 洪江市| 常州市| 南投县| 庄河市| 神木县| 化州市| 北辰区| 武宣县| 清新县| 东阿县| 蓝山县| 子洲县| 盱眙县| 肇庆市| 庆城县| 雅安市| 社会| 雷山县| 论坛| 苏州市| 诸城市| 泸州市| 伊吾县| 七台河市| 平昌县| 新营市| 巩义市| 库尔勒市| 云安县| 琼海市| 新平| 徐汇区| 竹溪县|